Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Akari Fukao"'
Publikováno v:
Journal of Pharmacological Sciences, Vol 147, Iss 1, Pp 58-61 (2021)
Nicotine administration enhances object recognition memory. However, target brain regions and cellular mechanisms underlying the nicotine effects remain unclear. In mice, the novel object recognition test revealed that systemic nicotine administratio
Externí odkaz:
https://doaj.org/article/f6b96e5203f94a01b41c77d63450a9d6
Autor:
Susumu Noguchi, Hiroaki Kawachi, Hiroshi Yoshida, Akari Fukao, Satoshi Terashita, Tatsuyoshi Ikeue, Sadao Horikawa, Takakazu Sugita
Publikováno v:
Case Reports in Oncology, Vol 11, Iss 2, Pp 562-566 (2018)
Nivolumab, an anti-PD-1 antibody, inhibits binding between PD-1 and PD-1 ligand and activates antigen-specific T cells that have become unresponsive to cancer cells. Although it is recommended as a second-line therapy in gene mutation-negative non-sm
Externí odkaz:
https://doaj.org/article/e3fee75e597e4012acce1622ffc1eabd
Publikováno v:
Journal of Pharmacological Sciences, Vol 147, Iss 1, Pp 58-61 (2021)
Nicotine administration enhances object recognition memory. However, target brain regions and cellular mechanisms underlying the nicotine effects remain unclear. In mice, the novel object recognition test revealed that systemic nicotine administratio
Autor:
Hiroaki Kawachi, Takahiro Kaki, Susumu Noguchi, Takakazu Sugita, Tatsuyoshi Ikeue, Keiichiro Suminaga, Akari Fukao, Sadao Horikawa, Satoshi Terashita
Publikováno v:
Lung Cancer: Targets and Therapy. 11:53-57
Purpose The effects of immune checkpoint inhibitors have been reported to be linked with immune-related adverse events (irAEs). In patients with advanced non-small-cell lung cancer, who tested positive for programmed death-ligand 1 (PD-L1), pembroliz
Autor:
Hirohito Esaki, Satoshi Deyama, Katsuyuki Kaneda, Shiho Ito, Naoya Nishitani, Akari Fukao, Shoma Izumi
Publikováno v:
Biologicalpharmaceutical bulletin. 44(7)
Nicotine has been known to enhance recognition memory in various species. However, the brain region where nicotine acts and exerts its effect remains unclear. Since the medial prefrontal cortex (mPFC) is associated with memory, we examined the role o
Autor:
Akari Fukao, Tomoko Tajiri, Susumu Noguchi, Takakazu Sugita, Sadao Horikawa, Eiichiro Tanaka, Hiroaki Kawachi, Hiroshi Yoshida, Tatsuyoshi Ikeue, Satoshi Terashita
Publikováno v:
Internal Medicine
Lymphoproliferative disorders can occur in patients with autoimmune disorders who undergo long-term methotrexate therapy (MTX-LPD). Although the manifestations of MTX-LPD are diverse, little attention is paid to endobronchial involvement. We herein d
Autor:
Katsuyuki Kaneda, Shuji Kaneko, Hitoki Sasase, Hirohito Esaki, Tong Zhang, Masaki Domoto, Akari Fukao, Satoshi Deyama, Eiichi Hinoi, Shiho Ito
Publikováno v:
Psychopharmacology. 236:2235-2242
N-[[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl]-l-valine methyl ester (5F-AMB) is a synthetic cannabinoid that has been distributed recently. Although inhalation of 5F-AMB produces adverse effects, such as impaired memory and disturbed consciousness
Autor:
Akari Fukao, Takakazu Sugita, Hiroshi Yoshida, Satoshi Terashita, Sadao Horikawa, Tatsuyoshi Ikeue, Susumu Noguchi, Hiroaki Kawachi
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 11, Iss 2, Pp 562-566 (2018)
Case Reports in Oncology, Vol 11, Iss 2, Pp 562-566 (2018)
Nivolumab, an anti-PD-1 antibody, inhibits binding between PD-1 and PD-1 ligand and activates antigen-specific T cells that have become unresponsive to cancer cells. Although it is recommended as a second-line therapy in gene mutation-negative non-sm
Autor:
Tomoko Tajiri, Susumu Noguchi, Takakazu Sugita, Sadao Horikawa, Satoshi Terashita, Hiroaki Kawachi, Tatsuyoshi Ikeue, Akari Fukao
Publikováno v:
Internal Medicine
A 69-year-old woman underwent left upper lobectomy for left upper lobe lung adenocarcinoma. She later perceived a left visual field defect, and a brain metastasis was detected on head magnetic resonance imaging (MRI). Epidermal growth factor receptor
Autor:
Susumu Noguchi, Hiroshi Yoshida, Akari Fukao, Sadao Horikawa, Issei Ohi, Satoshi Terashita, Eiichiro Tanaka, Takakazu Sugita, Tatsuyoshi Ikeue
Publikováno v:
Internal Medicine. 56:2785-2790
We herein describe the first known case of pleuritis caused by Mycobacterium kyorinense without pulmonary involvement. A 48-year-old man undergoing immunosuppressant therapy presented with cough and dyspnea. An accumulation of pleural fluid was noted